European Breast Cancer Council manifesto 2018: Genetic risk prediction testing in breast cancer.
BRCA1 Protein
/ genetics
BRCA2 Protein
/ genetics
Biomarkers, Tumor
/ genetics
Breast Neoplasms
/ genetics
Consensus
Direct-To-Consumer Screening and Testing
Early Detection of Cancer
Female
Genetic Counseling
Genetic Predisposition to Disease
Genetic Testing
Heredity
Humans
Molecular Targeted Therapy
Mutation
Pedigree
Phenotype
Precision Medicine
Predictive Value of Tests
Reproducibility of Results
Risk Assessment
Risk Factors
BRCA1/BRCA2
Breast cancer
Direct-to-consumer tests
Genetic counselling
Genetic testing
Regulation
Journal
European journal of cancer (Oxford, England : 1990)
ISSN: 1879-0852
Titre abrégé: Eur J Cancer
Pays: England
ID NLM: 9005373
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
26
07
2018
revised:
18
09
2018
accepted:
20
09
2018
pubmed:
25
11
2018
medline:
6
5
2020
entrez:
25
11
2018
Statut:
ppublish
Résumé
European Breast Cancer Council manifesto and supporting article on genetic risk prediction testing in breast cancer, presented at the 11th European Breast Cancer Conference in Barcelona, Spain.
Identifiants
pubmed: 30471647
pii: S0959-8049(18)31389-3
doi: 10.1016/j.ejca.2018.09.019
pii:
doi:
Substances chimiques
BRCA1 Protein
0
BRCA1 protein, human
0
BRCA2 Protein
0
BRCA2 protein, human
0
Biomarkers, Tumor
0
Types de publication
Journal Article
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
45-53Subventions
Organisme : Cancer Research UK
ID : 10119
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 10124
Pays : United Kingdom
Organisme : Department of Health
ID : RP-PG-0707-10031
Pays : United Kingdom
Organisme : Department of Health
ID : RP-PG-1214-20016
Pays : United Kingdom
Informations de copyright
Copyright © 2018. Published by Elsevier Ltd.